Forteo Voluntary Patient Registry: 3-Year Progress on a Prospective Osteosarcoma Surveillance Study

Trial Profile

Forteo Voluntary Patient Registry: 3-Year Progress on a Prospective Osteosarcoma Surveillance Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2014

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Osteoporosis
  • Focus Adverse reactions
  • Sponsors Eli Lilly
  • Most Recent Events

    • 22 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top